Factors and Mechanisms for Pharmacokinetic Differences between Pediatric Population and Adults
about
Early Gelatinase Activity Is Not a Determinant of Long-Term Recovery after Traumatic Brain Injury in the Immature MouseTowards a rational design of solid drug nanoparticles with optimised pharmacological properties.Age, Weight, and CYP2D6 Genotype Are Major Determinants of Primaquine Pharmacokinetics in African Children.Risk factors for adverse drug reactions in pediatric inpatients: a systematic review.Efficacy and safety of praziquantel in preschool-aged and school-aged children infected with Schistosoma mansoni: a randomised controlled, parallel-group, dose-ranging, phase 2 trialAdjusting ferritin concentrations for inflammation: Biomarkers Reflecting Inflammation and Nutritional Determinants of Anemia (BRINDA) project.Discordant temporal development of bacterial phyla and the emergence of core in the fecal microbiota of young children.Effect of Kidney Function on Drug Kinetics and Dosing in Neonates, Infants, and ChildrenAdverse reactions following routine anticholinergic eye drops in a paediatric population: an observational cohort studyAntecedents of inflammation biomarkers in preterm newborns on days 21 and 28.Review of commonly used age-based weight estimates for paediatric drug dosing in relation to the pharmacokinetic properties of resuscitation drugs.Off-label use of rilpivirine in combination with emtricitabine and tenofovir in HIV-1-infected pediatric patients: A multicenter studyPopulation Pharmacokinetics and Pharmacodynamics of Lumefantrine in Young Ugandan Children Treated With Artemether-Lumefantrine for Uncomplicated Malaria.Pediatric Biopharmaceutical Classification System: Using Age-Appropriate Initial Gastric Volume.Ontogeny of mammalian metabolizing enzymes in humans and animals used in toxicological studies.Renal Function Descriptors in Neonates: Which Creatinine-Based Formula Best Describes Vancomycin Clearance?Metabolomic analysis for the study of maturation in pediatrics: Effect of confounding factors in a pilot study.The Role of Pharmacotherapy in the Treatment of Adolescent Substance Use DisordersSkin absorption through atopic dermatitis skin: a systematic review.Impact of disease, drug and patient adherence on the effectiveness of antiviral therapy in pediatric HIV.Efficacy, safety and drug survival of conventional agents in pediatric psoriasis: A multicenter, cohort study.An investigation of the mutagenic activity of salamide - a major impurity of hydrochlorothiazide.Efficacy and safety of inhaled corticosteroids relative to fluticasone propionate: a systematic review of randomized controlled trials in asthma.Pharmacokinetics and Pharmacokinetic/Pharmacodynamic Relationships of Etravirine in HIV-1-Infected, Treatment-Experienced Children and Adolescents in PIANO.Pharmacokinetics of darunavir after administration of an oral suspension with low-dose ritonavir and with or without food.Perioperative treatment of hemophilia A patients: blood group O patients are at risk of bleeding complications.Pharmacokinetic changes of antibiotic, antiviral, antituberculosis and antifungal agents during extracorporeal membrane oxygenation in critically ill adult patients.Computerized pediatric oncology prescriptions review by pharmacist: A descriptive analysis and associated risk factors.Drugs Being Eliminated via the Same Pathway Will Not Always Require Similar Pediatric Dose Adjustments.Genetic Programming of Hypertension.A pharmacokinetic model for amiodarone in infants developed from an opportunistic sampling trial and published literature data.Treosulfan Pharmacokinetics and its Variability in Pediatric and Adult Patients Undergoing Conditioning Prior to Hematopoietic Stem Cell Transplantation: Current State of the Art, In-Depth Analysis, and Perspectives.Reference Intervals for Urinary Cotinine Levels and the Influence of Sampling Time and Other Predictors on Its Excretion Among Italian Schoolchildren.Efficacy and safety of ascending doses of praziquantel against Schistosoma haematobium infection in preschool-aged and school-aged children: a single-blind randomised controlled trial.Demographic Composition of Select Oncologic New Molecular Entities Approved by the FDA Between 2008 and 2017
P2860
Q27340373-7CE67CC8-45BB-4839-879B-F4D925AAA583Q30372133-E8E0618B-764E-4334-B9B6-FDDF4C1C71AAQ33601837-0C5C26CE-9084-48F5-8796-2AE325EB83C3Q33757095-BDA98981-E210-4A9D-B166-72674FE94F13Q33800953-DD94706D-1EE1-499A-97EE-87BDC1AF3461Q33852303-2266D53A-7A21-4201-B932-5ED16D39CC7FQ35796665-10EAD486-80DA-426B-955D-CABD56FA2E6AQ36322918-2AF9E301-1609-4FAE-BACC-9E47FD35BEA4Q36406014-9BF525D8-85F4-4326-B5EF-846F59F4AFD2Q36563594-B4CAAAA0-8682-48EA-8882-542F7359739AQ36806593-F221556F-7D77-40BE-82BE-7E61790BF132Q37205614-94407B46-3FED-45CD-98A9-767A225F33A2Q37279764-22CDBB28-F320-4CBB-90A8-DF42E32B6EA6Q37600374-5B45D3AA-5237-4252-B8F2-845EE50BCFE1Q38003479-EF08509F-843A-4D32-9322-ECE31D3CDF27Q38594191-64BD9F8F-2F82-43DD-BEBA-50A8C61738FCQ38686721-44B496DC-8ACE-4A8B-8410-CC42997559E2Q38950639-DD04B312-13E6-43F7-9952-4AADBEC92AE6Q38957449-2855EF12-557A-45CC-9074-D153A809F0CCQ39064765-9B1175B5-AF67-4695-8958-FECE6B2C0857Q39108777-397188C3-E617-433E-BC7E-EDBD93DD236DQ39239980-4E2F0B37-A810-41DC-B7DE-7FEC64E50572Q40104404-2D4A7012-5BDC-49CF-90F7-CCA0EC6595D4Q40722214-AE3478A0-9FA7-4D0B-8772-8BE057A489CCQ42199714-D7D04CA9-81DD-44A9-B49D-A532B95C5421Q45881897-DFAE79D1-B3C1-4531-80DA-D00931AD0F2DQ47632337-59EB6D5A-3F14-4E2B-8759-49239B0B79DBQ48101439-5C76D7C4-8E37-4388-AB5F-95EAD723B349Q49330212-84F6B63B-ABB4-4F55-9E72-342CBEAA5567Q49520111-361CC9D7-89F5-4793-B5B2-BDB27CD699B1Q50045350-A232CEA5-C354-4624-84D5-97A83B8B1638Q52647269-7F8C592D-AB32-4556-B427-115B4BBD5448Q54229077-935BC3F4-2C19-4CB4-8343-EBDF015FD400Q55006301-16BA4778-0BBA-4819-B282-8B8309DABB85Q58697688-11C70E2B-192C-4151-875D-AAC98612E51B
P2860
Factors and Mechanisms for Pharmacokinetic Differences between Pediatric Population and Adults
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 07 February 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Factors and Mechanisms for Pha ...... ediatric Population and Adults
@en
Factors and Mechanisms for Pha ...... diatric Population and Adults.
@nl
type
label
Factors and Mechanisms for Pha ...... ediatric Population and Adults
@en
Factors and Mechanisms for Pha ...... diatric Population and Adults.
@nl
prefLabel
Factors and Mechanisms for Pha ...... ediatric Population and Adults
@en
Factors and Mechanisms for Pha ...... diatric Population and Adults.
@nl
P2093
P2860
P1433
P1476
Factors and Mechanisms for Pha ...... ediatric Population and Adults
@en
P2093
Alfredo Hernandez
Eva Fernandez
Jose T Ramos
Marta Arteta
Pilar Tejada
Raul Perez
P2860
P356
10.3390/PHARMACEUTICS3010053
P577
2011-02-07T00:00:00Z